Research puts doubt on super aspirins
New research to be published may put two of this year's fastest selling new drugs, Monsanto's Celebrex and Merck's Vioxx, under a cloud. These so-called super aspirins may prevent the healing of
New research to be published may put two of this year's fastest selling new drugs, Monsanto's Celebrex and Merck's Vioxx, under a cloud. These so-called super aspirins may prevent the healing of